Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth

Oncogene

Volumn 23, Issue 33, 2004, Pages 5632-5642

  Mao, Xinliang ^a   Seidlitz, Eric ^b   Truant, Ray ^a   Hitt, Mary ^a   Ghosh, Hara P ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Adenovirus vector; Apoptosis; Lung cancer; TSLC1; Tumorigenesis

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; PDZ PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN TSLC1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FEMALE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; TUMOR CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; MALE; NICK END LABELING;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 3342928043     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207756     Document Type: Article

References (30)

1. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen SM, Launonen V and Winqvist R. (2002). Genes Chromosomes Cancer, 34, 384-389.
2. Ashe PC and Berry MD. (2003). Biol. Psychiatry, 27, 199-214.
3. Aznar S and Lacal JC. (2001). Cancer Lett., 165, 1-10.
4. Fukami F, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S and Murakami Y. (2003). Int. J. Cancer, 107, 53-59.
5. Fujita E, Soyama A and Momoi T. (2003). Exp. Cell Res., 287, 57-66.
6. Fukuhara H, Kuramochi M, Fukami T, Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T, Shuin T, Kitamura T, Reeves RH and Murakami Y. (2002). Jpn. J. Cancer Res., 93, 605-609.
7. Fukuhara H, Masuda M, Yageta M, Fukami T, Kuramochi M, Maruyama T, Kitamura T and Murakami Y. (2003). Oncogene, 22, 6160-6165.
8. Hall A. (1998). Science, 279, 509-514.
9. Harris BZ and Lim WA. (2001). J. Cell Sci., 114, 3219-3231.
10. Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kawata S, Kimura W, Nishizuka S and Murakami Y. (2002). Jpn. J. Cancer Res., 93, 857-860.
11. Hoover KB and Bryant PJ. (2000). Curr. Opin. Cell Biol., 12, 229-234.
12. Ito A, Okada M, Uchino K, Wakayama T, Koma Y, Iseki S, Tsubota N, Okita Y and Kitamura Y. (2003). Lab. Invest., 87, 1175-1183.
13. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG and Goggins M. (2002). Cancer Biol. Ther., 1, 293-296.
14. Ji L, Fang B, Yen N, Fong K, Minna JD and Roth JA. (1999). Cancer Res., 59, 3333-3339.
15. Katsuda K, Kataoka M, Uno F, Murakami T, Kondo T, Roth JA, Tanaka N and Fujiwara T. (2002). Oncogene, 21, 2108-2113.
16. Kuramochi M, Fukuhara H, Nokubuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH and Murakami Y. (2001). Nat. Genet., 27, 427-430.
17. Mao X, Seidlitz E, Ghosh K, Murakami Y and Ghosh HP. (2003). Cancer Res., 63, 7979-7985.
18. Marfatia SM, Leu RA, Branton D and Chishti AH. (1995). J. Biol. Chem., 270, 715-719.
19. Marfatia SM, Morais-Cabral JH, Kim AC, Byron O and Chishti AH. (1997). J. Biol. Chem., 272, 24191-24197.
20. Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A and Murakami Y. (2002). J. Biol. Chem., 277, 31014-31019.
21. Murakami Y, Nobukuni T, Tamura K, Maruyama T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, Frischmeyer P, Hunt P and Reeves RH. (1998). Proc. Natl. Acad. Sci. USA, 95, 8153-8156.
22. Ng P and Graham FL. (2002). Methods Mol. Med., 69, 389-414.
23. Roz L, Gramegna M, Ishii H, Croce CM and Sozzi G. (2002). Proc. Natl. Acad. Sci. USA, 99, 3615-3620.
24. Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA and Ramesh R. (2000). Gene Therapy, 7, 2051-2057.
25. Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, Chada S and Ramesh R. (2002). Oncogene, 21, 4558-4566.
26. Sheng M and Sala C. (2001). Annu. Rev. Neurosci., 24, 1-29.
27. Smith SA, Holik P, Stevens J, Mazoyer S, Melis R, Williams B, White R and Albertsen H. (1996). Genomics, 31, 145-150.
28. Tran YK, Bogler O, Gorse KM, Wieland I, Green MR and Newsham IF. (1999). Cancer Res., 59, 35-43.
29. Uchino K, Ito A, Wakayama T, Koma Y, Okada T, Ohbayashi C, Iseki S, Kitamura Y, Tsubota N, Okita Y and Okada M. (2003). Cancer, 98, 1002-1007.
30. Yageta M, Masami K, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M and Murakami Y. (2002). Cancer Res., 62, 5129-5133.